Boston Scientific’s Investment in Millipede
In January, Boston Scientific (BSX) closed an investment in Millipede and entered into an acquisition option agreement with the company. Millipede is a private company that has developed the IRIS annuloplasty ring system targeted for treating mitral regurgitation.